Published online before print September 28, 2009, doi: 10.1161/CIRCULATIONAHA.109.868885
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2009;120:1513-1523.)
© 2009 American Heart Association, Inc.
Molecular Cardiology |
Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells
From the Sohnis Family Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, the Rappaport Family Institute for Research in the Medical Sciences (L.Z., O.C., G.A., I.H., A.G., L.G.), the Cardiology Department, Rambam Medical Center (L.G.), and the Biotechnology Interdisciplinary Unit (L.Z.), Technion–Israel Institute of Technology, Haifa, Israel, and the Division of Pediatric Hematology Oncology, Children’s Hospital, Boston, Mass (I.-H.P.).
Correspondence to Lior Gepstein, MD, PhD, Technion’s Faculty of Medicine, PO Box 9649, Haifa, 31096, Israel. E-mail mdlior{at}tx.technion.ac.il
Received March 27, 2009; accepted July 31, 2009.
Background— The ability to derive human induced pluripotent stem (hiPS) cell lines by reprogramming of adult fibroblasts with a set of transcription factors offers unique opportunities for basic and translational cardiovascular research. In the present study, we aimed to characterize the cardiomyocyte differentiation potential of hiPS cells and to study the molecular, structural, and functional properties of the generated hiPS-derived cardiomyocytes.
Methods and Results— Cardiomyocyte differentiation of the hiPS cells was induced with the embryoid body differentiation system. Gene expression studies demonstrated that the cardiomyocyte differentiation process of the hiPS cells was characterized by an initial increase in mesoderm and cardiomesoderm markers, followed by expression of cardiac-specific transcription factors and finally by cardiac-specific structural genes. Cells in the contracting embryoid bodies were stained positively for cardiac troponin-I, sarcomeric 
-actinin, and connexin-43. Reverse-transcription polymerase chain reaction studies demonstrated the expression of cardiac-specific sarcomeric proteins and ion channels. Multielectrode array recordings established the development of a functional syncytium with stable pacemaker activity and action potential propagation. Positive and negative chronotropic responses were induced by application of isoproterenol and carbamylcholine, respectively. Administration of quinidine, E4031 (IKr blocker), and chromanol 293B (IKs blocker) significantly affected repolarization, as manifested by prolongation of the local field potential duration.
Conclusions— hiPS cells can differentiate into myocytes with cardiac-specific molecular, structural, and functional properties. These results, coupled with the potential of this technology to generate patient-specific hiPS lines, hold great promise for the development of in vitro models of cardiac genetic disorders, for drug discovery and testing, and for the emerging field of cardiovascular regenerative medicine.
CLINICAL PERSPECTIVE
Related Articles:
-
Clinical Summaries
Circulation 2009 120: 1457-1458.[Extract] [Full Text]
- Induced Pluripotent Stem Cells: It’s Like Déjà Vu All Over Again
- Katja Schenke-Layland and W. Robb MacLellan
Circulation 2009 120: 1462-1464.[Extract] [Full Text]
This article has been cited by other articles:
 |
|
 |
|
  K. Schenke-Layland and W. R. MacLellan Induced Pluripotent Stem Cells: It's Like Deja Vu All Over Again Circulation, October 13, 2009; 120(15): 1462 - 1464. [Full Text] [PDF]
|
|